{"text_format":"2","workbook":"xlsx","n_sheets":9,"sheets":["Key Highlights","Net Sales - Prod","Net Sales - Geo","Royalty","Other Revenue","Gross Profit","Adj. EBITDA","Profit","Core EPS"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":2,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Key Highlights","index":0,"n_rows":38,"n_cols":5,"rows_kept":38,"cut":false,"hidden":false,"merged":[[0,1,0,2],[0,3,0,4]]}
[null,"Actual1",null,"Variance","Variance"]
["€ million","2024","2023","Actual rates","CER"]
["Revenue",6152,5252,0.17138267899499274,0.19141803549777411]
["Net sales",5613,4867,0.15332415813838265,0.1744456261705653]
["Royalty income and fees",78,77,1.1272833155411678E-2,1.2968874610583004E-2]
["Other revenue",461,308,0.49703627739448913,0.50179059167548501]
["Adjusted Gross Profit",4819,4033,0.19497585964689129,0.22192316055743083]
["Gross Profit",4400,3545,0.24113599996064916,0.27253497922345515]
["Amortization of intangible assets linked to sales",-419,-488,-0.1403950481146474,-0.14065058505630482]
["Marketing and selling expenses",-2075,-1594,0.30228369842147151,0.30356989634431059]
["Research and development expenses",-1781,-1630,9.245098262994321E-2,8.8718593250527528E-2]
["General and administrative expenses",-272,-230,0.18485766207579535,0.18329013461530921]
["Other operating income/expenses (-)",564,566,-3.4884024660152839E-3,2.6757905709787239E-3]
["Adjusted EBIT",836,657,0.27078574712242404,0.466721492560421]
["Impairment, restructuring and other income/expenses (-)",488,-53,">-100%",">-100%"]
["EBIT (operating profit)",1324,604,">100%",">100%"]
["Net financial expenses (-)",-160,-163,-1.3360008997697062E-2,-1.6005318646363332E-2]
["Share of profit/loss (-) of associates",0,0,"N/A","N/A"]
["Profit before income taxes",1163,441,">100%",">100%"]
["Income tax expenses (-)",-98,-98,-4.519622379341573E-3,4.318503741980588E-2]
["Profit from continuing operations",1065,343,">100%",">100%"]
["Profit/loss (-) from discontinued operations",0,0,"N/A","N/A"]
["Profit",1065,343,">100%",">100%"]
["Attributable to UCB shareholders",1065,343,">100%",">100%"]
["Attributable to non-controlling interests",0,0,"N/A","N/A"]
["Adjusted EBITDA",1476,1349,9.4143810229799854E-2,0.17945239721087772]
["Capital expenditure (including intangible assets)",322,316,1.8987341772151899E-2]
["Net debt (-)",-1453.5084760000002,-2176.840404,-0.33228523628597617]
["Operating cash flow from continuing operations",1242,761,0.63206307490144542]
["Weighted average number of shares – non diluted (million)",190,190,0]
["EPS (€ per weighted average number of shares – non diluted)",5.6070182062546552,1.8080244543951813,">100%",">100%"]
["Core EPS (€ per weighted average number of shares – non diluted)",4.9840471301024349,4.1951473328672311,0.18805055809470689,0.32]
[]
[]
["1: Due to rounding, some financial data may not add up in the tables included in this management report."]
["2: CER: constant exchange rates and excluding hedging."]
[]
["In the event of any differences between this Excel file and the Annual or Half-Year Report, the information included in the Report shall prevail."]

{"sheet":"Net Sales - Prod","index":1,"n_rows":20,"n_cols":5,"rows_kept":20,"cut":false,"hidden":false,"merged":[[0,1,0,2],[0,3,0,4]]}
[null,"Actual","Actual","Variance","Variance"]
["€ million","2024","2023","Actual rates","CER"]
["Core products",5077,4240,0.19729153633686297,0.20962109041871957]
["Immunology",2743,2295,0.19518227961328108,0.20359468070362313]
["CIMZIA®**",2033,2087,-2.5877504172037127E-2,-1.762287372903984E-2]
["BIMZELX®*",607,148,">100%",">100%"]
["EVENITY®**",103,60,0.71187870970461098,0.70555820784573475]
["Neurology",2334,1945,0.1997806869468606,0.21673290438177012]
["BRIVIACT®**",686,576,0.19097482916251002,0.19203879826043271]
["KEPPRA®** (including KEPPRA®** XR /       E KEPPRA®**)",582,636,-8.4234165486603993E-2,-5.1208833244182878E-2]
["FINTEPLA®**",340,226,0.50282304310583725,0.50367129703506608]
["VIMPAT®**",329,394,-0.1660169249583551,-0.14171043951029716]
["RYSTIGGO®**",202,19,">100%",">100%"]
["NAYZILAM®**",124,94,0.32525453379531694,0.32589192289567798]
["ZILBRYSQ®*",72,0,"N/A","N/A"]
["Established brands",517,577,-0.10436067974334921,-8.4175394363645087E-2]
["Net sales before hedging",5593,4817,0.16117552647389224,0.1744456261705653]
["Designated hedges reclassified to net sales",19,50,"N/A"]
["Total net sales",5613,4867,0.15332415813838265,0.1744456261705653]
["In the event of any differences between this Excel file and the Annual or Half-Year Report, the information included in the Report shall prevail."]

{"sheet":"Net Sales - Geo","index":2,"n_rows":51,"n_cols":7,"rows_kept":51,"cut":false,"hidden":false,"merged":[[0,1,0,2],[0,3,0,4],[0,5,0,6]]}
[null,"Actual","Actual","Variance actual rates","Variance actual rates","Variance CER","Variance CER"]
["€ million","2024","2023","€ million","%","€ million","%"]
["Net sales - U.S.",3036,2454,582,0.23717284853680803,584,0.23776786632974345]
["CIMZIA®**",1289,1364,-75,-5.4883540139392138E-2,-74,-5.4428987757312371E-2]
["BRIVIACT®**",540,445,95,0.21382805551634826,95,0.21441184557141685]
["FINTEPLA®**",294,201,93,0.46302891602073137,93,0.46373254697955346]
["BIMZELX®*",287,9,278,">100%",278,">100%"]
["RYSTIGGO®**",184,19,165,">100%",165,">100%"]
["NAYZILAM®**",124,94,30,0.32525453379531694,30,0.32589192289567798]
["KEPPRA®**",123,132,-9,-6.7541965213515145E-2,-9,-6.7093494540212698E-2]
["VIMPAT®**",56,96,-40,-0.4128568469928583,-40,-0.4125744567111348]
["ZILBRYSQ®*",56,0,56,"N/A",56,"N/A"]
["Established brands",83,94,-12,-0.12787622392945389,-12,-0.12745677878420952]
["Net sales - Europe",1582,1397,186,0.13283461046502978,181,0.12944956641199554]
["CIMZIA®**",436,428,8,1.9218587265861831E-2,6,1.4038720185319282E-2]
["BIMZELX®*",255,112,143,">100%",142,">100%"]
["KEPPRA®**",199,205,-6,-2.8938269893293178E-2,-6,-2.9314328963920458E-2]
["BRIVIACT®**",120,110,10,9.5152542903440232E-2,10,9.4450124255921253E-2]
["VIMPAT®**",116,140,-24,-0.16952606173160814,-24,-0.17052486896929414]
["EVENITY®**",103,60,43,0.71187870970461098,42,0.70555820784573475]
["FINTEPLA®**",41,21,20,0.92629535991419654,20,0.91965408128759396]
["RYSTIGGO®**",8,0,8,"N/A",8,"N/A"]
["ZILBRYSQ®*",8,0,7,"N/A",7,"N/A"]
["Established brands",296,321,-24,-7.6031567476687892E-2,-25,-7.8731569033423099E-2]
["Net sales - Japan",257,269,-12,-4.3320876777055449E-2,9,3.267615064579845E-2]
["VIMPAT®**",85,83,2,1.9945607389386034E-2,8,0.1013780973273596]
["E KEPPRA®**JP",65,97,-32,-0.32832785645501983,-27,-0.27470154176562045]
["BIMZELX®*",32,16,16,">100%",19,">100%"]
["CIMZIA®**",28,39,-10,-0.26211001888846075,-8,-0.20319684516555109]
["RYSTIGGO®**",10,0,9,"N/A",10,"N/A"]
["ZILBRYSQ®*",8,0,8,"N/A",9,"N/A"]
["FINTEPLA®**",2,1,1,">100%",2,">100%"]
["BRIVIACT®**",1,0,1,"N/A",2,"N/A"]
["Established brands",25,33,-8,-0.23334019027432917,-6,-0.17527354811326165]
["Net sales - International markets",718,697,20,2.9262615004734264E-2,67,9.634208347593716E-2]
["CIMZIA®**",280,257,23,8.8227332036468376E-2,39,0.15260350386799773]
["KEPPRA®**",196,202,-7,-3.3871118516609629E-2,9,4.4210668732644148E-2]
["VIMPAT®**",71,75,-4,-5.1298568564308408E-2,-1,-1.2627806758177837E-2]
["BRIVIACT®**",24,21,3,0.14050754935361748,3,0.155426416599593]
["BIMZELX®*",33,12,22,">100%",22,">100%"]
["FINTEPLA®**",2,3,0,-0.15694046139838558,0,-0.15694046139838558]
["NAYZILAM®**",0,0,0,"N/A",0,"N/A"]
["EVENITY®**",0,0,0,"N/A",0,"N/A"]
["RYSTIGGO®**",0,0,0,"N/A",0,"N/A"]
["ZILBRYSQ®*",0,0,0,"N/A",0,"N/A"]
["Established brands",111,127,-16,-0.12491510229677485,-5,-4.1562911576721172E-2]
["Net sales before hedging",5593,4817,776,0.16117552647389224,840,0.1744456261705653]
["Designated hedges reclassified to net sales",19,50,-30,-0.60983611334067145]
["Total net sales",5613,4867,746,0.15332415813838265,840,0.1744456261705653]
[]
["In the event of any differences between this Excel file and the Annual or Half-Year Report, the information included in the Report shall prevail."]

{"sheet":"Royalty","index":3,"n_rows":7,"n_cols":5,"rows_kept":7,"cut":false,"hidden":false,"merged":[[0,1,0,2],[0,3,0,4]]}
[null,"Actual","Actual","Variance","Variance"]
["€ million","2024","2023","Actual rates","CER"]
["Biotechnology IP",60,55,9.41371821238456E-2,9.4330238708595221E-2]
["Other",19,23,-0.18734955683514168,-0.18205092330268849]
["Royalty income and fees",78,77,1.1272833155411678E-2,1.2968874610583004E-2]
[]
["In the event of any differences between this Excel file and the Annual or Half-Year Report, the information included in the Report shall prevail."]

{"sheet":"Other Revenue","index":4,"n_rows":7,"n_cols":5,"rows_kept":7,"cut":false,"hidden":false,"merged":[[0,1,0,2],[0,3,0,4]]}
[null,"Actual","Actual","Variance","Variance"]
["€ million","2024","2023","Actual rates","CER"]
["Contract manufacturing sales",79,119,-0.34112720139084091,-0.33295556339543791]
["Other",382,189,">100%",">100%"]
["Other revenue",461,308,0.49703627739448913,0.50179059167548501]
[]
["In the event of any differences between this Excel file and the Annual or Half-Year Report, the information included in the Report shall prevail."]

{"sheet":"Gross Profit","index":5,"n_rows":14,"n_cols":5,"rows_kept":14,"cut":false,"hidden":false,"merged":[[0,1,0,2],[0,3,0,4]]}
[null,"Actual","Actual","Variance","Variance"]
["€ million","2024","2023","Actual rates","CER"]
["Revenue",6152,5252,0.17138267899499274,0.19141803549777411]
["Net sales",5613,4867,0.15332415813838265,0.1744456261705653]
["Royalty income and fees",78,77,1.1272833155411678E-2,1.2968874610583004E-2]
["Other revenue",461,308,0.49703627739448913,0.50179059167548501]
["Cost of sales",-1752,-1707,2.6509223362456792E-2,2.5298138568030381E-2]
["Cost of sales products and services",-1227,-1115,9.9965642998356252E-2,0.10065805530171122]
["Royalty expenses",-106,-104,2.1851887808431881E-2,-4.3307632408653906E-3]
["Adjusted Gross Profit",4819,4033,0.19497585964689129,0.22192316055743083]
["Amortization of intangible assets linked to sales",-419,-488,-0.1403950481146474,-0.14065058505630482]
["Gross Profit",4400,3545,0.24113599996064916,0.27253497922345515]
[]
["In the event of any differences between this Excel file and the Annual or Half-Year Report, the information included in the Report shall prevail."]

{"sheet":"Adj. EBITDA","index":6,"n_rows":19,"n_cols":5,"rows_kept":19,"cut":false,"hidden":false,"merged":[[0,1,0,2],[0,3,0,4]]}
[null,"Actual","Actual","Variance","Variance"]
["€ million","2024","2023","Actual rates","CER"]
["Revenue",6152,5252,0.17138267899499274,0.19141803549777411]
["Net sales",5613,4867,0.15332415813838265,0.1744456261705653]
["Royalty income and fees",78,77,1.1272833155411678E-2,1.2968874610583004E-2]
["Other revenue",461,308,0.49703627739448913,0.50179059167548501]
["Adjusted Gross Profit",4819,4033,0.19497585964689129,0.22192316055743083]
["Gross Profit",4400,3545,0.24113599996064916,0.27253497922345515]
["Amortization of intangible assets linked to sales",-419,-488,-0.1403950481146474,-0.14065058505630482]
["Marketing and selling expenses",-2075,-1594,0.30228369842147151,0.30356989634431059]
["Research and development expenses",-1781,-1630,9.245098262994321E-2,8.8718593250527528E-2]
["General and administrative expenses",-272,-230,0.18485766207579535,0.18329013461530921]
["Other operating income/expenses (-)",564,566,-3.4884024660152839E-3,2.6757905709787239E-3]
["Total operating expenses",-3564,-2888,0.234385555827927,0.23165654144880485]
["Adjusted EBIT",836,657,0.27078574712242404,0.466721492560421]
["Add: Amortization of intangible assets",467,533,-0.12410091813933252,-0.12417653825368911]
["Add: Depreciation charges",174,159,9.9339347845447276E-2,9.6940396677598364E-2]
["Adjusted EBITDA",1476,1349,9.480385365036427E-2,0.17945239721087772]
["In the event of any differences between this Excel file and the Annual or Half-Year Report, the information included in the Report shall prevail."]

{"sheet":"Profit","index":7,"n_rows":18,"n_cols":5,"rows_kept":18,"cut":false,"hidden":false,"merged":[[0,1,0,2],[0,3,0,4]]}
[null,"Actual","Actual","Variance","Variance"]
["€ million","2024","2023","Actual rates","CER"]
["Adjusted EBIT",836,657,0.27082297440225467,0.466721492560421]
["Impairment charges",-73,-5,">100%",">100%"]
["Restructuring expenses",-25,-13,0.92710386081082619,0.93084193471573062]
["Gain/loss (-) on disposals",578,-24,">-100%",">-100%"]
["Other income/expenses (-)",8,-11,">-100%",">-100%"]
["Total impairment, restructuring and other income/expenses (-)",488,-53,">-100%",">-100%"]
["EBIT (operating profit)",1324,604,">100%",">100%"]
["Net financial expenses (-)",-160,-163,-1.3360008997697062E-2,-1.6005318646363332E-2]
["Result from associates",0,0,"N/A","N/A"]
["Profit before income taxes",1163,441,">100%",">100%"]
["Income tax expenses",-98,-98,-4.519622379341573E-3,4.318503741980588E-2]
["Profit from continuing operations",1065,343,">100%",">100%"]
["Profit/loss (-) from discontinued operations",0,0,"N/A","N/A"]
["Profit",1065,343,">100%",">100%"]
[]
["In the event of any differences between this Excel file and the Annual or Half-Year Report, the information included in the Report shall prevail."]

{"sheet":"Core EPS","index":8,"n_rows":15,"n_cols":5,"rows_kept":15,"cut":false,"hidden":false,"merged":[[0,1,0,2],[0,3,0,4]]}
[null,"Actual","Actual","Variance","Variance"]
["€ million","2024","2023","Actual rates","CER"]
["Profit",1065,343,">100%",">100%"]
["Total impairment, restructuring and other income (-) /expenses",-488,53,">-100%",">-100%"]
["Income tax on impairment, restructuring and other expenses (-)/ credit",15,-11,">-100%",">-100%"]
["Financial one-off income (-)/expenses",0,0,"N/A","N/A"]
["Income tax on financial one-off income/expenses (-)",0,0,"N/A","N/A"]
["Profit (-)/loss from discontinued operations",0,0,"N/A","N/A"]
["Amortization of intangibles linked to sales",419,488,-0.1403950481146474,-0.14065058505630482]
["Income tax on amortization of intangibles linked to sales",-65,-77,-0.16131496186978406,-0.16156427761295036]
["Core profit",947,796,0.18990551564235664,0.32]
["Weighted average number of shares (million)",190,190,1.5613456304627209E-3]
["Core EPS",4.9840471301024349,4.1951473328672311,0.18805055809470689,0.32]
[]
["In the event of any differences between this Excel file and the Annual or Half-Year Report, the information included in the Report shall prevail."]